BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

Pancreaticoduodenectomy or Pages on BioPortfolio:

BioPortfolio - Pancreaticojejunostomy
216 cases of pancreaticoduodenectomy: risk factors for postoperative complications. BACKGROUND/AIMS: Surgical resection remains the best treatment
for. ...
http://www.bioportfolio.com/indepth/Pancreaticojejunostomy.h...

BioPortfolio - Duodenal Neoplasms
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy, Pancreatic Neoplasms; Biliary Tract
...
http://www.bioportfolio.com/indepth/Duodenal_Neoplasms.html...

BioPortfolio - Neoprene
Postoperative complications linked to pancreaticoduodenectomy. An analysis of pancreatic stump management. AIMS: To analyze the role of different procedures
...
http://www.bioportfolio.com/indepth/Neoprene.html...

Biotechnology, Pharmaceutical and Life Science Email addresses for ...
BioPortfolio the comprehensive email list supplier for data, information, search engine and services on biotechnology, pharmaceutical and healthcare ...
http://www.bioportfolio.com/advertis/bioemail.htm...

Results from other life science and pharmaceutical sites:

[Pancreaticoduodenectomy for cancer of the head of...[J Chir ...
2004]; Pancreaticoduodenectomy with or without distal gastrectomy and extended ... 2003]; Risk factors of pancreatic leakage after pancreaticoduodenectomy. ...
http://www.ncbi.nlm.nih.gov/pubmed/18438276...

Quality of Life and Outcomes After Pancreaticoduodenectomy
Pancreaticoduodenectomy is gaining acceptance and is being performed in increasing numbers for various malignant and benign diseases of the pancreas and
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14...

How necessary is vagotomy after pancreaticoduodene ...
BACKGROUND/AIMS: Gastrectomy with gastrojejunostomy is a fundamental step used for the restoration of the alimentary tract after pancreaticoduodenectomy or ...
http://www.ncbi.nlm.nih.gov/pubmed/15783042...

PANCREAS SUMMARY
Extended pancreaticoduodenectomy could not be indicated, while extended lymph node “sampling” could potentially be of value for tailoring future adjuvant ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20...

Preoperative Liver Function Tests and Hemoglobin w...[J ...
MATERIALS AND METHODS: We identified 452 patients who received a pancreaticoduodenectomy from 1990-2007. Clinicopathological data was collected
for each ...
http://www.ncbi.nlm.nih.gov/pubmed/18787909...

Relation of perioperative deaths to hospital volume among patients ...
METHODS: Discharge abstracts from 1972 patients who had undergone pancreaticoduodenectomy or total pancreatectomy for malignancy in New York State
between ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=12...

Role of somatostatin in the prevention of pancreat...[World J Surg ...
Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and ...
http://www.ncbi.nlm.nih.gov/pubmed/12732998...

Pancreatectomy for chronic pancreatitis.
Nineteen patients underwent pancreaticoduodenectomy, seventy-seven 80-95% ... The choice between pancreaticoduodenectomy or distal resection of 40-80% or ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...

Expandable metal biliary stents before pancreatico...[Clin ...
2007]; Pancreaticoduodenectomy following endoscopic placement of an ... 1999]; Pancreaticoduodenectomy after placement of endobiliary metal stents. ...
http://www.ncbi.nlm.nih.gov/pubmed/16361049...

One Thousand Consecutive Pancreaticoduodenectomies
To trace the evolution of pancreaticoduodenectomy from the decade of the 1960s through the ... A total of 405 patients underwent pancreaticoduodenectomy for
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo